sponsored byAAAS Golden Fund

EurekAlert!, a service of AAAS
Home About us
Advanced Search
30-Aug-2014 14:44
US Eastern Time

Username:

Password:

Register

Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books

Meetings

Multimedia

Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation

Calendar

Submit a Calendar Item

Subscribe/Sponsor

Links & Resources

Portals

RSS Feeds

Accessibility Option On

Options

Portal Home

Glossary

Background Articles

Research Papers

Meetings

Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 776-800 out of 889.

<< < 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 > >>

Public Release: 19-Nov-2012
UBC professor wins Canada's top pharmaceutical research award
University of British Columbia microbiologist Robert E.W. Hancock has received the Prix Galien 2012 Research Award, widely considered the most prestigious honor in Canadian pharmaceutical research and innovation. Hancock is being recognized for pioneering work unraveling the complex interactions between antibiotics and bacteria.
Innovation Life Canada

Contact: Silvia Moreno-Garcia
silvia.moreno-garcia@science.ubc.ca
604-822-5001
University of British Columbia

Public Release: 19-Nov-2012
ACS Nano
Rice unveils super-efficient solar-energy technology
Rice University scientists have unveiled a revolutionary new technology that uses nanoparticles to convert solar energy directly into steam. The new "solar steam" method from Rice's Laboratory for Nanophotonics is so effective it can even produce steam from icy cold water. Details of the solar steam method were published online today in ACS Nano. The technology's inventors said they expect it will first be used in sanitation and water-purification applications in the developing world.
Welch Foundation, Bill and Melinda Gates Foundation

Contact: Mike Williams
mikewilliams@rice.edu
713-348-6728
Rice University

Public Release: 19-Nov-2012
NIH awards Georgia malaria research consortium up to $19.4 million contract
The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded a five-year contract of up to $19.4 million, depending on contract options exercised, to establish the Malaria Host-Pathogen Interaction Center (MaHPIC). The consortium includes researchers at Emory University, with partners at the University of Georgia (UGA), the Georgia Institute of Technology (Georgia Tech) and the Centers for Disease Control and Prevention (CDC). The Yerkes National Primate Research Center of Emory University will administer the contract.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Holly Korschun
hkorsch@emory.edu
404-727-3990
Emory Health Sciences

Public Release: 16-Nov-2012
GW Researcher receives grant to study parasitic worm role in bile duct cancer in Southeast Asia
Paul Brindley, Ph.D., professor of microbiology, immunology, and tropical medicine at the George Washington University School of Medicine and Health Sciences, was the recipient of a $1.7 million grant from the National Cancer Institute to study the behavior of a parasitic worm, rampant in Southeast Asia, known to cause infections that contribute to liver cancer.
NIH/National Cancer Institute

Contact: Lisa Anderson
lisama2@gwu.edu
202-994-3121
George Washington University

Public Release: 15-Nov-2012
World Health Organisation’s Framework Convention on Tobacco Control
Tobacco Control
Cash cuts increase smoking death risk for world's poor, study says
Proposed funding cuts within the international body responsible for tobacco control will leave the world's poorest countries more vulnerable to smoking-related diseases, a study suggests.

Contact: Edd McCracken
edd.mccracken@ed.ac.uk
44-013-165-14400
University of Edinburgh

Public Release: 14-Nov-2012
Genes & Development
How cells in the nose detect odors
A team of scientists, led by neurobiologists at the University of California, Riverside, has studied the olfactory receptor for detecting carbon dioxide in Drosophila, and identified a large multi-protein complex in olfactory neurons, called MMB/dREAM, that plays a major role in selecting the carbon dioxide receptors to be expressed in appropriate neurons.
Whitehall Foundation

Contact: Iqbal Pittalwala
iqbal@ucr.edu
951-827-6050
University of California - Riverside

Public Release: 14-Nov-2012
New England Journal of Medicine
Possible link between immune system and Alzheimer's
An international research team including scientists from the University of Toronto's Faculty of Medicine has discovered a link between a mutation in an immune system gene and Alzheimer's disease.

Contact: Nicole Bodnar
nicole.bodnar@utoronto.ca
416-978-5811
University of Toronto

Public Release: 14-Nov-2012
Cell Host & Microbe
Tolerance to malaria by means of iron control
In a study published in the latest issue of Cell Host & Microbe, scientists at Instituto Gulbenkian de Ciencia, Portugal, discovered that the development of severe malaria can be prevented by a mechanism that controls the accumulation of iron in tissues of the infected host. Expression of a gene that neutralizes iron inside cells, named H-Ferritin, reduces oxidative stress preventing tissue damage and death. This protective mechanism provides a new therapeutic strategy against malaria.
Fundação para a Ciência e a Tecnologia, and others

Contact: Ana Mena
anamena@igc.gulbenkian.pt
351-214-407-959
Instituto Gulbenkian de Ciencia

Public Release: 14-Nov-2012
PLOS ONE
The hidden consequences of helping rural communities in Africa
Improving water supplies in rural African villages may have negative knock-on effects and contribute to increased poverty, new research published today [Nov. 14] has found. Rural development initiatives across the developing world are designed to improve community wellbeing and livelihoods but a study of Ethiopian villages by researchers at the Universities of Bristol and Addis Ababa in Africa has shown that this can lead to unforeseen consequences caused by an increase in the birth rate in the absence of family planning.
Leverhulme Trust

Contact: Philippa Walker
philippa.walker@bristol.ac.uk
01-179-287-777
University of Bristol

Public Release: 14-Nov-2012
American Society of Tropical Medicine and Hygiene 61st Annual Meeting
Meningitis A vaccine breaks barrier; first to gain approval to travel outside cold chain
Signaling a potential breakthrough for immunization programs in resource-poor countries, researchers today announced at the American Society of Tropical Medicine and Hygiene conference that regulatory authorities--after conducting a rigorous review of stability data--will for the first time allow a vaccine in Africa to be transported and stored for as long as four days without refrigeration or even an icepack.

Contact: Coimbra Sirica
CSirica@burnesscommunications.com
301-943-3287
Burness Communications

Public Release: 13-Nov-2012
Science
Scientists question the designation of some emerging diseases
The Ebola, Marburg and Lassa viruses are commonly referred to as emerging diseases, but leading scientists say these life-threatening viruses have been around for centuries.

Contact: Robert Cahill
Robert.Cahill@uth.tmc.edu
713-500-3030
University of Texas Health Science Center at Houston

Public Release: 13-Nov-2012
Second most common infection in the US proving harder to treat with current antibiotics
Certain types of bacteria responsible for causing urinary tract infections, the second-most-common infection in the US, are becoming more difficult to treat with current antibiotics, according to new research from Extending the Cure (ETC), a project of the Center for Disease Dynamics, Economics & Policy. ETC released the research via its online ResistanceMap, an online tool created to track changes in antibiotic drug use and resistance, which features analysis using ETC's Drug Resistance Index.
Center for Disease Dynamics, Economics & Policy

Contact: Dionne Dougall-Bass
dionne@burnesscommunications.com
301-961-5803
Burness Communications

Public Release: 13-Nov-2012
Open access initiative reveals drug hits for deadly neglected tropical diseases
The Drugs for Neglected Diseases initiative (DNDi) and Medicines for Malaria Venture (MMV) announce today the identification of three chemical series targeting the treatment of deadly neglected tropical diseases, through DNDi's screening of MMV's open access Malaria Box. The resulting DNDi screening data are among the first data generated on the Malaria Box to be released into the public domain, exemplifying the potential of openly sharing drug development data for neglected patients.

Contact: Oliver Yun
oyun@dndi.org
646-266-5216
Drugs for Neglected Diseases Initiative

Public Release: 13-Nov-2012
PLOS Medicine
Common enzyme deficiency may hinder plans to eradicate malaria
In malaria-endemic countries, 350 million people are predicted to be deficient in an enzyme that means they can suffer severe complications from taking primaquine, a key drug for treating relapsing malaria, according to a study funded by the Wellcome Trust and published in this week's PLOS Medicine.

Contact: Sumrina Yousufzai
syousufzai@plos.org
415-568-3164
PLOS

Public Release: 13-Nov-2012
American Society of Tropical Medicine and Hygiene 61st Annual Meeting
American Journal of Tropical Medicine and Hygiene
Scientists report injectable formulation of malaria parasites achieve controlled infection
In a breakthrough that could accelerate malaria vaccine and drug development, scientists announced today that, for the first time ever, human volunteers were infected with malaria via a simple injection of cryopreserved sterile parasites that were harvested from the salivary glands of infected mosquitoes in compliance with regulatory standards. The parasites had been frozen in a vial for more than two years.

Contact: Bridget DeSimone
bdesimone@burnesscommunications.com
301-280-5735
Burness Communications

Public Release: 13-Nov-2012
American Society of Tropical Medicine and Hygiene 61st Annual Meeting
Experts report 1 of 2 remaining types of polio virus may be eliminated in Pakistan
Polio cases worldwide reached historic lows in 2012, and for the first time there were no new outbreaks beyond countries already harboring the disease, leaving researchers confident that a massive and re-energized international campaign to eradicate polio is on a path to success, according to presentations today at the annual meeting of the American Society of Tropical Medicine and Hygiene.

Contact: Bridget DeSimone
bdesimone@burnesscommunications.com
301-280-5735
Burness Communications

Public Release: 12-Nov-2012
Nature Medicine
UNC, Vanderbilt discover a new live vaccine approach for SARS and novel coronaviruses
Collaborating researchers at the University of North Carolina and Vanderbilt University have found that accelerating the rate of mutations in the coronavirus responsible for deadly severe acute respiratory syndrome cripples the virus's ability to cause disease in animals.

Contact: Carole Bartoo
carole.bartoo@vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center

Public Release: 12-Nov-2012
Pneumonia remains the leading killer of children despite decline in global child deaths
Marking the fourth annual World Pneumonia Day, November 12th, world leaders including the UN Secretary General and the Global Coalition Against Child Pneumonia are calling for major efforts in the fight against childhood pneumonia, which remains the number one killer of children under age five. Pneumonia claimed 1.3 million lives in 2011 alone, and was responsible for nearly one in five global child deaths. A new report shows much more needs to be done.

Contact: Julie Younkin
jbuss@jhsph.edu
410-340-9784
International Vaccine Access Center

Public Release: 12-Nov-2012
American Society of Tropical Medicine and Hygiene 61st Annual Meeting
$3 million awarded to find biomarkers for potential test of cure for chagas disease
Today at the 61st Annual Meeting of the American Society of Tropical Medicine and Hygiene, the Drugs for Neglected Diseases initiative announces a new $3 million Strategic Translation Award from the Wellcome Trust to identify new biological markers for the evaluation of treatment efficacy in Chagas disease, a potentially fatal neglected tropical disease.

Contact: Oliver Yun
oyun@dndi.org
646-266-5216
Drugs for Neglected Diseases Initiative

Public Release: 12-Nov-2012
American Society of Tropical Medicine and Hygiene 61st Annual Meeting
PATH's Kent Campbell honored for lifetime achievement in the fight against malaria
Kent Campbell, PATH's Malaria Control Program director, received the distinguished Joseph Augustin LePrince Medal in recognition of outstanding work in the field of malariology at the American Society of Tropical Medicine and Hygiene's award ceremony.

Contact: Meg DeRonghe
mderonghe@path.org
206-302-4575
GMMB

Public Release: 12-Nov-2012
American Society of Tropical Medicine and Hygiene 61st Annual Meeting
List of diseases spread by deer tick grows, along with their range
An emerging tick-borne disease that causes symptoms similar to malaria is expanding its range in areas of the northeast where it has become well-established, according to new research presented today at the annual meeting of the American Society of Tropical Medicine and Hygiene.

Contact: Bridget DeSimone
bdesimone@burnesscommunications.com
301-280-5735
Burness Communications

Public Release: 11-Nov-2012
Nature Genetics
Gene variations linked to lung cancer susceptibility in Asian women
An international group of scientists has identified three genetic regions that predispose Asian women who have never smoked to lung cancer. The finding provides further evidence that risk of lung cancer among never-smokers, especially Asian women, may be associated with certain unique inherited genetic characteristics that distinguishes it from lung cancer in smokers.
NIH/National Cancer Institute

Contact: NCI Press Office
ncipressofficers@mail.nih.gov
301-496-6641
NIH/National Cancer Institute

Public Release: 9-Nov-2012
PLOS ONE
Study documents eating of soil, raw starch in Madagascar
A Cornell University study provides the first population-level data of pica in Madagascar -- the urge to eat dirt, raw starches, chalk, ash and other nonfoods.
National Geographic Society Conservation Trust

Contact: Syl Kacapyr
vpk6@cornell.edu
607-255-7701
Cornell University

Public Release: 9-Nov-2012
International African Vaccinology Conference
New England Journal of Medicine
RTS,S malaria candidate vaccine reduces malaria by approximately one-third in African infants
Results from a pivotal, large-scale Phase III trial, published online today in the New England Journal of Medicine, show that the RTS,S malaria vaccine candidate can help protect African infants against malaria. When compared to immunization with a control vaccine, infants (aged 6-12 weeks at first vaccination) vaccinated with RTS,S had one-third fewer episodes of both clinical and severe malaria and had similar reactions to the injection. In this trial, RTS,S demonstrated an acceptable safety and tolerability profile.

Contact: Preeti Singh
psingh@burnesscommunications.com
301-280-5722
Burness Communications

Public Release: 7-Nov-2012
Wake Forest Baptist research goes global with genetic center in India
World-renowned scientists are taking what they've learned from their multicenter research collaboration studying the health impact of fatty acids on diverse populations to set up a genetics center in India.
National Institutes of Health Fogarty Grant

Contact: Bonnie Davis
bdavis@wakehealth.edu
336-716-4977
Wake Forest Baptist Medical Center

Showing releases 776-800 out of 889.

<< < 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 > >>